Sarah Kathryn Rouan Viking Therapeutics, Inc. (VKTX) insider trading activity
Sarah Kathryn Rouan is Director of Viking Therapeutics, Inc.. Currently has a direct ownership of 0 shares of VKTX, which is worth approximately $0. The most recent transaction as insider was on Feb 08, 2024, when has been sold 25,000 shares (Common stock, par value $0.00001 per share) at a price of $28.05 per share, resulting in proceeds of $701,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
n/a
12M change
Total Value Held
$0
Sarah Kathryn Rouan Transaction History
Also insider at
SKR
Sarah Kathryn Rouan
Director
San Diego, CA